The ALS Therapy Development Institute (ALS TDI) is proud to announce that it will lead all research operations for Champion Insights—a new study planned to launch this fall in partnership with Answer ALS and Augie’s Quest to Cure ALS. This effort aims to uncover critical genetic and metabolic factors that may help explain the significantly higher incidence of amyotrophic lateral sclerosis (ALS) among endurance athletes, military service members, and other potentially high-risk groups.

A natural history study is an effort to gather as much data about a disease in as wide a population as possible.

In early June 2025, Timm Fenton set out to cross the country by bike while raising funds for the ALS Therapy Development Institute (ALS TDI) in an effort he is calling Pedals vs. ALS.

In anticipation of this year’s ALS Walk for Research, we’re interviewing the leaders of some of the event’s biggest and most successful teams. Today, we’re joined by Cory Fanelli of the team Chip Fanelli Fan Club.

The ALS Therapy Development Institute (ALS TDI) is proud to announce that it will lead all research operations for Champion Insights—a new study planned to launch this fall in partnership with Answer ALS and Augie’s Quest to Cure ALS. This effort aims to uncover critical genetic and metabolic factors that may help explain the significantly higher incidence of amyotrophic lateral sclerosis (ALS) among endurance athletes, military service members, and other potentially high-risk groups.

The ALS Therapy Development Institute (ALS TDI) is proud to announce that a collection of cells derived from ALS patient-derived induced pluripotent stem cell (iPSC) lines will now be made widely available to researchers around the world.